PLURI INC.
NASDAQ: PLUR (Pluri Inc.)
Last update: yesterday, 3:56PM0.990
-0.02 (-1.98%)
| Previous Close | 1.01 |
| Open | 1.04 |
| Volume | 69,810 |
| Avg. Volume (3M) | 20,439 |
| Market Cap | 12,485,222 |
| Price / Sales | 10.65 |
| 52 Weeks Range | |
| Earnings Date | 16 Sep 2025 - 22 Sep 2025 |
| Operating Margin (TTM) | -1,264.64% |
| Diluted EPS (TTM) | -3.63 |
| Quarterly Revenue Growth (YOY) | 501.40% |
| Total Debt/Equity (MRQ) | 6,456.94% |
| Current Ratio (MRQ) | 4.81 |
| Operating Cash Flow (TTM) | -17.31 M |
| Levered Free Cash Flow (TTM) | -11.34 M |
| Return on Assets (TTM) | -36.57% |
| Return on Equity (TTM) | -1,833.59% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Pluri Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | NA |
| AI Insight | NA |
| Weighted Average | 0.00 |
Select this tab to load the latest available analysis.
|
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 43.87% |
| % Held by Institutions | 19.40% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Winch Advisory Services, Llc | 30 Jun 2026 | 26 |
| Tfc Financial Management, Inc. | 30 Jun 2026 | 19 |
No data within this time range.
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |